VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.
VIVAN Therapeutics's investors include SFC Capital, European Innovation Council, VOYAGERS Health-Tech Fund, Reflect Ventures.
VIVAN Therapeutics is headquartered in London, United Kingdom.
VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.
VIVAN Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VIVAN Therapeutics — Funding & Investors." VCBacked, December 19, 2022, https://www.vcbacked.co/company/vivan-therapeutics. Accessed July 20, 2026.
VCBacked. (2022). VIVAN Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/vivan-therapeutics
{{cite web |title=VIVAN Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vivan-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated